3-methyleneindolenine has been researched along with Pulmonary Fibrosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oehme, FW; Pickrell, JA | 1 |
1 other study(ies) available for 3-methyleneindolenine and Pulmonary Fibrosis
| Article | Year |
|---|---|
Examining the risks and benefits of considering both the traditional dose--response and hormesis in arriving at an acceptable exposure level.
Topics: Carbon; Colorectal Neoplasms; Dose-Response Relationship, Drug; Erythrocytes; Humans; Indoles; Lead; Lung; No-Observed-Adverse-Effect Level; Pulmonary Fibrosis; Risk Assessment | 2006 |